Last updated at 02 Jul 2024 09:44 AM
Director
DIN: 05318875
Abdul Rahim Kadavath is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05318875.Abdul Rahim Kadavath is currently involved in 2 different roles. Their most recent position is with AISHAL MEDICITY PRIVATE LIMITED as a Individual Promoter. The first company Abdul Rahim Kadavath was appointed to as a director was ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED. Abdul Rahim Kadavath is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Abdul Rahim Kadavath is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05318875.Abdul Rahim Kadavath is currently involved in 2 different roles. Their most recent position is with AISHAL MEDICITY PRIVATE LIMITED as a Individual Promoter. The first company Abdul Rahim Kadavath was appointed to as a director was ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED. Abdul Rahim Kadavath is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
2y 8m 1y 4m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED | Director | 16-Aug-2012 |
| AISHAL MEDICITY PRIVATE LIMITED | Individual Promoter | 31-Mar-2022 |
| AISHAL MEDICITY PRIVATE LIMITED | Director | 31-Mar-2022 |